Medicare Materials

Your Results

• Insulin Prices Cut for More Patients as Eli Lilly Caves to Pressure

  March 07, 2023: Drug corporation Eli Lilly announced Wednesday that it will cap out-of-pocket patient costs for its two most popular insulin drugs, Humalog and Humulin, at $35 a month. Patients with private insurance and who use participating pha Read More >

• President Biden Goes to Bat for Retirees

  March 07, 2023: Senior Organization Applauds Effort to Extend Medicare Solvency and Further Lower Drug Prices for Older Americans The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, r Read More >

• Kaiser Health News: Biden Promises to Fight GOP on ‘Gutting’ Medicaid. Budget Talks Seem Like Another Story.

  March 02, 2023: Most lawmakers — Republicans and Democrats alike — have declared the marquee safety-net programs of Medicare and Social Security off-limits for cuts as a divided Washington heads for a showdown over the national debt and gover Read More >

• Position Paper: PRO Act

  March 01, 2023: The labor movement has been, and continues to be, the leading force in the fight to strengthen Social Security, Medicare and Medicaid, ensuring a measure of retirement security for all Americans. Our country, our democracy and our Read More >

• Tell Congress to Save Social Security

  February 27, 2023: Even though the extremist Republicans stood during the State of the Union to supposedly show “support” for Social Security and Medicare, they are scheming to cut our earned benefits. They aren’t even keeping it a secret, goi Read More >

• Caregiving Crisis Looms as Number of Older Americans Soars

  February 27, 2023: Experts examining numbers from the U.S. Census predict that long term care issues will become more serious as Americans live longer, given a national shortage of workers who provide caregiving services. At the outset of the COV Read More >

• Battle Over ‘Orphan Drugs’ Leads to Higher Drug Prices

  February 27, 2023: An “orphan drug” is a designation that rewards drug corporations for developing treatments for rare diseases. When a drugmaker wins approval for an orphan drug, the company is entitled to seven years of exclusive rights to the Read More >

• Steps to Hold Medicare Advantage Accountable are Not Cuts, Experts Say

  February 27, 2023: Two announcements by the Centers for Medicare and Medicaid Services (CMS) related to Medicare Advantage — an alternative to original Medicare, primarily run by major insurance companies — have brought additional discussion abo Read More >

• Take Action: Sign the Alliance’s Petition to Save Social Security

  February 27, 2023: Even though the extremist Republicans stood during the State of the Union to supposedly show “support” for Social Security and Medicare, they are scheming to cut our earned benefits. They aren’t even keeping it a secret, goi Read More >

• One in Four American Older Adults Needed Long Term Care for Themselves or a Loved One Last Year

  February 21, 2023: Twenty-four percent of U.S. adults ages 50 and older say they, or a loved one, needed long-term care in the past year, according to a recent Nexus Insights survey. According to the survey, most older adults said the process of Read More >